In a new perspective piece published in the Feb. 5 issue of Science, pharmacologist Namandje Bumpus, Ph.D.—who recently became the first African American woman to head a Johns Hopkins University School of Medicine department, ...
Feb 4, 2021
0
52
Tuberous sclerosis complex (TSC) afflicts as many as two million people around the world, affecting multiple organs, including lungs, brain, skin and kidneys. In about 80 percent of cases, it causes cysts and benign tumors ...
Feb 4, 2021
0
11
There is an impassioned debate taking place in medicine on whether race-based considerations should be a factor in research, diagnoses, or treatments. Those on one side assert that race should be ignored entirely because ...
Feb 3, 2021
0
4
The Canadian Neuromuscular Disease Registry (CNDR) was launched in 2010 to increase efficient patient access to cutting-edge research and clinical trials, to increase understanding of the natural history and epidemiology ...
Feb 2, 2021
0
2
Scientists have identified a group of drugs that may help stop a leading cause of vision loss after making an unexpected discovery that overturns a fundamental belief about DNA.
Feb 1, 2021
0
426
Four million UK patients could benefit annually from genetic testing before being prescribed common medicines, according to new research from the University of East Anglia (UEA) in collaboration with Boots UK and Leiden University ...
Jan 29, 2021
0
4
Scientists at St. Jude Children's Research Hospital and their colleagues have published a detailed account of SJMB03, a clinical trial for pediatric patients with medulloblastoma. Additionally, they report results of the ...
Jan 27, 2021
0
5
A microbe found in the colon and commonly associated with the development of colitis and colon cancer also may play a role in the development of some breast cancers, according to new research from investigators with the Johns ...
Jan 6, 2021
0
13
(HealthDay)—As America rolls out a nationwide coronavirus vaccination campaign this week, experts help answer your questions about the new COVID-19 vaccines.
Dec 16, 2020
0
3
A new drug discovered through a research collaboration between the University at Buffalo and Tetra Therapeutics took a major step toward becoming a first-in-class treatment for Fragile X Syndrome, a leading genetic cause ...
Dec 12, 2020
0
66
